1. Introduction {#sec1}
===============

Coenzyme Q~10~ (CoQ~10~), a vitamin-like substance, is involved in energy production and is a lipid-soluble antioxidant \[[@B1]--[@B3]\]. Many studies have reported a relationship between CoQ~10~ and aging. For example, the amount of CoQ~10~ in muscles and organs decreases with age \[[@B4]\], as does the serum CoQ~10~ concentration and that of the reduced form \[[@B5]\] in healthy adults. Both blood levels and the ratio of the reduced form of CoQ~10~ concentration to total coenzyme Q~10~ in hospitalized elderly people were lower than that in the healthy elderly people \[[@B6]\]. Also, many studies have shown associations between serum CoQ~10~ status and health \[[@B7]--[@B11]\]. In addition, CoQ~10~ supplementation has been shown to ameliorate the symptoms of some geriatric disorders and to improve the quality of life of humans and some laboratory animals. CoQ~10~ supplementation ameliorates high blood pressure \[[@B12]\], glucose metabolism in diabetes \[[@B13]\], and the symptoms of Parkinson\'s disease \[[@B14]\] and reduces peripheral oxidative stress and inflammation in interferon *β*-1a-treated multiple sclerosis \[[@B15]\]. It can also increase the vitality of patients undergoing medical treatment and of the elderly residents of nursing homes \[[@B16]--[@B18]\]. Furthermore, it alleviates fatigue in patients with chronic fatigue syndrome \[[@B19], [@B20]\], hyperlipidemia \[[@B21]\], and in those with end-stage heart failure awaiting cardiac transplantation \[[@B22]\]. In older rats, CoQ~10~ supplementation has been shown to alleviate diabetes-induced learning and memory deficits and to improve cognitive performance when administered at a high dose \[[@B23]\]. In the senescence-accelerated prone 8 mouse, CoQ~10~ supplementation counteracts the deleterious effects of physical exercise-derived reactive oxygen species, improving mitochondrial function \[[@B24]\]. Thus, CoQ~10~ may be useful as an antiaging and health-supporting supplement.

In general, the absorption of compounds from the gastrointestinal tract is one of the most important determinants of oral bioavailability. Intestinal absorption of supplemental CoQ~10~ is slow and limited because of the compound\'s hydrophobicity and high molecular weight. Many types of CoQ~10~ delivery system have been developed that aim to increase the bioavailability of supplemental CoQ~10~, such as self-emulsifying drug delivery systems, nanotechnology-based drug delivery systems, cyclodextrin complexes, CoQ~10~-solanesyl poly(ethylene glycol) succinate micelles, and a reduced form of CoQ~10~ that is both emulsified and solubilized \[[@B25]--[@B27]\]. In addition, the concurrent consumption of food enhances the rate of the absorption of orally administered supplemental CoQ~10~ \[[@B28]\]. Therefore, the consumption of CoQ~10~-fortified foods may be a useful way of increasing the bioavailability of CoQ~10~.

It is well known that the absorption of nutrients, such as vitamins and minerals, is affected by the food items concurrently consumed or their components. For example, the enhancement of *β*-carotene absorption by mayonnaise consumption \[[@B29]\], of carotenoid absorption by avocado or avocado oil consumption \[[@B30]\], of vitamin E absorption by egg consumption \[[@B31]\], and of nonheme iron absorption by meat protein and vitamin C consumption, have been reported \[[@B32]--[@B34]\]. Conversely, some dietary fibers suppress the absorption of *β*-carotene, lycopene, and lutein \[[@B35]\]. Additionally, tannins, phytic acid, polyphenols, and calcium inhibit the absorption of nonheme iron \[[@B36]--[@B39]\]. Thus, the absorption of supplemental CoQ~10~ may also be affected by the food or a component with which it is consumed, although no previous studies have addressed this issue. Therefore, knowledge of the food items that could enhance the absorption of orally administered CoQ~10~ is crucial for the development of appropriate functional CoQ~10~-fortified foods.

Previously, we investigated the association between dietary habits and serum CoQ~10~ levels before and after long-term supplementation with a reduced form of CoQ~10~ \[[@B40], [@B41]\]. People with higher basal serum CoQ~10~ concentrations tended to consume more soy products \[[@B40]\], and those who had a higher increase in serum CoQ~10~ concentrations after the 1-year supplementation tended to consume more dairy products and eggs \[[@B41]\]. These results remind us that soy products, dairy products, and eggs might positively affect the absorption of CoQ~10~ supplements.

In this study, we investigated the effect of various foods on the bioavailability of supplemental CoQ~10~ using P30, a granulated and reduced form of CoQ~10~ supplement, and a typical Japanese meal, consisting of steamed rice, grilled salmon with marinated Japanese radish, boiled spinach, and soup. P30 was suspended in the soup or raw egg sauce in advance, before being provided to the participants. Miso soup, milk soup, and raw egg sauce were used as foods containing soy products, daily products, and eggs, respectively. Clear soup, which is seasoned with salt, was used as a reference food. The soup consumed was different in each experiment. Serum CoQ~10~ concentration was determined before, and 1.5, 3, and 5 h after eating the meals, and the bioavailability of CoQ~10~ was compared among the various foods that were concurrently consumed.

2. Materials and Methods {#sec2}
========================

2.1. CoQ~10~ Supplements {#sec2.1}
------------------------

A granulated, solubilized, and reduced form of CoQ~10~ supplement, P30, was used in the study. P30 contains 30 w/w% of reduced CoQ~10~ (120 mg per sachet), dextrin, gum Arabic, and L-ascorbate. These supplements were provided by the Kaneka Corporation (Osaka, Japan).

2.2. Study Design {#sec2.2}
-----------------

Thirteen healthy volunteers (1 man and 12 women), who were students or staff at Wayo Women\'s University, participated in the study. Each participant took a CoQ~10~ supplement with a meal on four occasions, with the food type containing the CoQ~10~ differing on each occasion. [Table 1](#tab1){ref-type="table"} shows the meal composition, the sauce of the CoQ~10~, the nutrient content of the meals. Using the data by Kubo et al. \[[@B42]\], CoQ~10~ content obtained from the meals in the clear soup, miso soup, milk soup, and raw egg source experiments were estimated as 0.52, 0.55, 0.56, and 0.59 mg, respectively, and these were the less than one two-hundredth of the CoQ~10~ supplements ingested. It suggests that the effect of CoQ~10~ content in meals itself was vanishingly low. The number of participants in each experiment is shown in [](#supplementary-material-1){ref-type="supplementary-material"}. Photos of the meal components provided for the subjects are shown in [](#supplementary-material-1){ref-type="supplementary-material"}. In the experiments, each participant ingested 120 mg of reduced CoQ~10~ (a sachet of P30) suspended in the food (indicated by red arrowheads in [](#supplementary-material-1){ref-type="supplementary-material"}). In the meals containing P30, the ratio of the concentrations of the reduced form of CoQ~10~ concentration to total coenzyme Q~10~ was \>99%. To minimize the number of confounding factors, the same meal was consumed in each experiment, with the exception of the food item containing the P30.

The nutrient content of the meals was estimated using Calorie Make software (Toyo System Science Co., Ltd., Yokohama, Japan). The consumption of the meals started around 12:00 h, at least 3 h after breakfast. The control and test experiments were performed between March and December 2018 at intervals of 6--14 weeks. All subjects gave their informed consent for inclusion before they participated in this study. This study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Wayo Women\'s University Human Research Ethics Committee (no. 1734).

2.3. Blood Collection and CoQ~10~ Measurements {#sec2.3}
----------------------------------------------

Blood samples were drawn from a vein at the baseline (just before meal ingestion), and 1.5, 3, and 5 h after the start of the meal, and serum was obtained by centrifugation after clot formation. Quantitative analysis of serum CoQ~10~ concentration was measured by Kaneka Techno Research Co., Ltd., using liquid chromatography with tandem mass spectrometry (LC/MS/MS) \[[@B43], [@B44]\]. In brief, 0.7 mL of the isopropanol was added to 0.1 mL of serum, mixed, and stored at −80°C until just before the analysis. After centrifugation, the supernatant was filtered through a membrane filter. Then, 200 *μ*L aliquots were mixed with 200 *μ*L of methanol and 50 *µ*L of oxidized CoQ~9~ (50 ng/mL in 2-propanol) as an internal standard and used as the sample for LC/MS/MS, which was performed using an AB Sciex Triple Quad 5500 LC-MS/MS system and a reversed-phase octadecyl-silica column (AB Sciex, Framingham, MA, USA). The intra- and interday coefficients of variation for CoQ~10~ were less than 2 and 10%, respectively.

2.4. Data Analysis {#sec2.4}
------------------

The increase in concentration of CoQ~10~ in the serum after the ingestion of a CoQ~10~-suspended test meal (ΔCoQ~10~) was calculated by subtracting the baseline value, and numerical data are expressed as mean ± SD. To compare the bioavailabilities of CoQ~10~, the areas under the serum CoQ~10~ concentration-time curves up to 5 h after ingestion (ΔAUC~0--5~) were calculated. These data were analyzed using one-way analysis of variance (ANOVA) with unpaired and repeated measures, and the differences between the means were evaluated by Holm--Bonferroni post hoc testing using js-STAR ver. 9. 3. 0j web application software (<http://www.kisnet.or.jp/nappa/software/star/>). *P* \< 0.05 was considered to represent statistical significance.

3. Results {#sec3}
==========

Thirteen healthy volunteers (1 man and 12 women) participated in the study. Each ingested a CoQ~10~ supplement in the form of suspended a suspension in a food item on up to four separate occasions. Twelve participated in the first experiment (supplemental CoQ~10~ in clear soup as a reference), thirteen participated in the second experiment (supplemental CoQ~10~ in miso soup), nine participated in the third experiment (supplemental CoQ~10~ in milk soup), and thirteen participated in the fourth experiment (supplemental CoQ~10~ in a raw egg sauce). The participation of each individual and the increases in serum total CoQ~10~ concentration after each meal are shown in Tables [](#supplementary-material-1){ref-type="supplementary-material"} and [](#supplementary-material-1){ref-type="supplementary-material"}, respectively. ΔAUC~0--5~ was also calculated for each participant ([](#supplementary-material-1){ref-type="supplementary-material"}).

First, the increase in serum total CoQ~10~ (ΔCoQ~10~) concentration after each of the four experiments were compared using unpaired one-way ANOVA and Holm--Bonferroni post hoc testing because some participants missed in the first and third experiments. The concentration achieved following the consumption of P30 in miso soup was significantly higher than that achieved following consumption of the raw egg sauce after 1.5 h and higher than that achieved following all three other meals after 3 h ([](#supplementary-material-1){ref-type="supplementary-material"}). There were significant differences in ΔAUC~0--5~ between the clear soup and miso soup days, and between the miso soup and raw egg sauce days ([](#supplementary-material-1){ref-type="supplementary-material"}). The ΔAUC~0--5~ following miso soup ingestion was 4.44 ± 1.40 *μ*mol h/L, which is approximately 1.5- and 1.6-fold higher (*P* \< 0.05) than that on the clear soup (2.97 ± 1.11 *μ*mol h/L) and raw egg sauce (2.84 ± 1.36 *μ*mol h/L) days, respectively ([](#supplementary-material-1){ref-type="supplementary-material"}).

Then, we reanalyzed the data from the eight participants (numbers 3, 4, 5, 8, 9, 11, 12, and 13) who had participated in all of the four experiments ([](#supplementary-material-1){ref-type="supplementary-material"}), using one-way ANOVA with repeated measures ([Figure 1](#fig1){ref-type="fig"}). The ΔCoQ~10~ on the miso soup day was significantly higher than on the raw egg sauce days after 1.5 h and higher than on all of the other 3 days 3 h after ingestion ([Figure 1(a)](#fig1){ref-type="fig"}). The mean ΔAUC~0--5~ on the miso soup day was 4.94 ± 1.51 *μ*mol h/L, which was 1.6∼1.7-fold higher (*P* \< 0.05) than that on the clear soup (3.08 ± 1.33 *μ*mol h/L), milk soup (2.95 ± 1.07 *μ*mol h/L), and raw egg sauce (3.05 ± 1.64 *μ*mol h/L) days, respectively ([Figure 1(b)](#fig1){ref-type="fig"}).

These results demonstrate that the absorption rate and bioavailability of supplemental reduced CoQ~10~ up to 5 h after ingestion was increased by suspending it in miso soup. However, this effect was abolished when the CoQ~10~ was suspended in raw egg sauce, even if miso soup was ingested at the same time (experiment 4).

4. Discussion {#sec4}
=============

In this study, we determined whether the absorption of a CoQ~10~ supplement would be affected when it was suspended in specific foods. There were no differences in either ΔCoQ~10~ or ΔAUC~0--5~ among participants who consumed a clear soup and test meals on different days, with the exception of the day they consumed the supplement in miso soup. Both the ΔCoQ~10~ at 3 h and the ΔAUC~0--5~ for CoQ~10~ after ingestion of the miso soup was significantly higher than after ingestion of clear soup, milk soup, or raw egg sauce ([Figure 1(a)](#fig1){ref-type="fig"}). This result suggests that the suspension of P30 in miso soup may be an effective way of increasing the bioavailability of orally administered CoQ~10~, especially for older people, as the frequency of miso soup consumption is increased with age in Japanese \[[@B45]\].

Interestingly, the effect of miso soup on the absorption of CoQ~10~ was abolished when P30 was suspended in raw egg sauce, despite miso soup also being consumed. This suggests that an interaction between the reduced form of CoQ~10~ and a component of miso might be necessary for the increase in bioavailability of CoQ~10~ achieved by the consumption of miso soup. The absorption of orally administered CoQ~10~ is improved when emulsified with a surfactant that has a higher hydrophile-lipophile balance value \[[@B46]\]. Soy proteins have emulsifying and interfacial properties \[[@B47]\], and the amino-carbonyl reaction of soy proteins with sugar improves their emulsifying properties \[[@B48]\]. Some of the soy proteins in miso are modified by the amino-carbonyl reaction, which explains its brown color. Thus, these modified proteins in miso might be candidates for the components responsible for the enhancement of CoQ~10~ absorption, by emulsification. Besides, miso and soybean extracts improve zinc absorption via increasing cell surface abundance of a zinc transporter \[[@B49], [@B50]\]. Some components in miso might affect the expression and the activity of a CoQ~10~ transporter protein. However, further studies are required to determine the identity of the active component(s) and the mechanisms involved in the enhanced absorption of CoQ~10~. The miso used in the present study contained only 3.76 and 0.02 *μ*g of the reduced and oxidized forms of CoQ~10~ per g miso (data not shown), and 10 g of the miso was used for the preparation of one serving of miso soup; therefore, it is unlikely that the CoQ~10~ contributed by the miso is involved in the enhancement in bioavailability of CoQ~10~.

We also estimated the ΔAUC value for the reduced form of CoQ~10~ in the previously published study to compare these with the ΔAUC~0--5~ values obtained in the present study. Hosoe et al. performed a single-dose experiment after meal ingestion using 150 mg of the reduced form of CoQ~10~ in a soft capsule \[[@B27]\]. The estimated ΔAUC for the first 6 h after ingestion (ΔAUC~0--6~) in this study was 2.9 *μ*mol h/L, whereas the ΔAUC~0--5~ in our control experiment, in which 120 mg of the reduced form of CoQ~10~ was consumed in a clear soup was 2.97 ± 1.11 *μ*mol h/L (Experiment 1 in [](#supplementary-material-1){ref-type="supplementary-material"}), suggesting that similar results can be obtained when the reduced form of CoQ~10~ is administered. The ΔAUC~0--5~ associated with P30-plus-miso ingestion (4.44 ± 1.40 *μ*mol h/L, Experiment 2 in [](#supplementary-material-1){ref-type="supplementary-material"}) was \>1.5 times higher than those associated with the ingestion of other foods (clear soup, milk soup, and raw egg sauce), implying that the ingestion of CoQ~10~ suspended in miso soup is one of the best ways of increasing its bioavailability, at least, when P30 is used.

One limitation of our study was that the serum concentrations of CoQ~10~ were determined only up to 5 h after ingestion because of the research environment and availability of the participants. In contrast, in most previous studies, these concentrations were determined up to 12 or 24 h after a single dose of CoQ~10~. One could argue that miso soup may accelerate rather than enhance CoQ~10~ absorption, as the maximum CoQ~10~ concentration or the maximum CoQ~10~ concentration-time could not be determined. The half-life of CoQ~10~ in plasma may reach 33 h, and 5 to 6 days were required for plasma CoQ~10~ levels to return to baseline following a single dose \[[@B51]\]. The possibility of overestimation of the effect of miso soup on CoQ~10~ absorption cannot be denied.

Another limitation of our study was that there is no negative control, i.e., meals alone. In the previous reports, there was no placebo control for the determination of the absorption/bioavailability of CoQ~10~ supplements \[[@B25]--[@B27], [@B52]--[@B55]\]. Also, the effect of CoQ~10~ contents in the provided meals seemed to be extremely low as the estimated CoQ~10~ amount was less than one two-hundredth of the CoQ~10~ supplements ingested. However, these remain in a matter of speculation.

To further characterize the effects of miso soup ingestion on the bioavailability of CoQ~10~, it would be of interest to compare the serum concentrations of CoQ~10~ after multiple meals of miso soup or water containing P30 with or after meals for several weeks. The significance of the present findings will be evaluated by performing such a clinical experiment in the near future.

5. Conclusions {#sec5}
==============

In conclusion, the ingestion of a granulated and reduced form of CoQ~10~ in miso soup increased the bioavailability of CoQ~10~ by ∼1.5 times over its ingestion under the other conditions tested. Thus, the absorption of a CoQ~10~ supplement can be enhanced by combining it with specific food substances, such as miso, in addition to taking it with a meal *per se*.
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###### 

Figure S1: Meals provided to the participants. Figure S2: Changes in serum total CoQ~10~ using unpaired one-way ANOVA. Table S1: Participation in each of the four experiments. Table S2: The increase in serum total CoQ~10~ concentration of each subject after the consumption of each food type.

###### 

Click here for additional data file.

![Changes in serum total CoQ~10~ concentration (a) and a comparison of ΔAUC~0--5~ (b) after the consumption of P30 in clear soup, P30 in miso soup, P30 in milk soup, or P30 in raw egg sauce. 120 mg of CoQ~10~ was administered. In [Figure 1(a)](#fig1){ref-type="fig"}, the open circle represents P30 in clear soup, closed circle represents P30 in miso soup, open triangle represents P30 in milk soup, and open square indicates P30 in raw egg sauce. Data are mean ± SD for the eight individuals who participated in all four of the experiments. [Figure 1(b)](#fig1){ref-type="fig"} shows box plots for the ΔAUC~0--5~ for these eight participants. The boundary of the box closest to zero indicates the 25th percentile, the line within the box indicates the median, the multiplication sign within the box indicates the mean, and the boundary of the box farthest from the origin indicates the 75th percentile. Whiskers above and below the box indicate the 10th and 90th percentiles. Data were analyzed with one-way analysis of variance with repeated measures, and differences between the means were evaluated using Holm--Bonferroni post hoc tests. Different lower case letters indicate significant differences, with *P* \< 0.05.](JNME2020-5349086.001){#fig1}

###### 

Meal menus for each experiment.

  Experiment no.                 1                                                               2              3              4
  ------------------------------ --------------------------------------------------------------- -------------- -------------- ------------------------------------
  Experiment                     Clear soup                                                      Miso soup      Milk soup      Raw egg sauce
                                                                                                                               
  *Meal menu*                                                                                                                   
  Main dish                      Grilled salmon with Japanese radish marinated in citrus juice                                 
  Side dish                      Boiled spinach flavored with bonito flakes and soy sauce                                      
  Staple food                    Rice                                                            Rice           Rice           Rice with stirred raw egg sauce^a^
  Soup                           Clear soup^a^                                                   Miso soup^a^   Milk soup^a^   Miso soup
  Other                          ---                                                             ---            ---            ---
                                                                                                                               
  *Nutrient content per serve*                                                                                                 
  Energy (kcal)                  336                                                             356            437            430
  Protein (g)                    20.1                                                            21.5           25.1           27.5
  Fat (g)                        3.6                                                             4.3            9.3            9.4
  Carbohydrate (g)               54.1                                                            56.5           61.3           56.4
  CoQ~10~ (mg)^b^                120                                                             120            120            120

^a^P30 was suspended in this food item; ^b^only CoQ~10~ obtained from P30 is recorded.

[^1]: Academic Editor: C. S. Johnston
